Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5408573 | 0.77 | CA12 (0.33) | CA12CA1CA9KDM4E | |
| SCHEMBL352075 | 0.77 | CA12 (0.33) | CA12CA1CA9KDM4EPOLB | |
| SCHEMBL8768383 | 0.75 | CA12 (0.32) | CA12CA1CA9KDM4E | |
| Acetic Acid SCHEMBL3486649 | 0.72 | FFAR3 (0.35) | CA12CA1CA9POLB | |
| Ethylenediamine SCHEMBL7125278 | 0.69 | KDM4E (0.31) | KDM4E | |
| SCHEMBL5664428 | 0.68 | TSHR (0.35) | — | |
| SCHEMBL11711601 | 0.68 | NPSR1 (0.39) | CA12CA1CA9ALDH1A1POLB | |
| SCHEMBL8629433 | 0.67 | CRBN (0.32) | — | |
| SCHEMBL18271092 | 0.66 | HTT (0.36) | CA12CA1CA9KDM4EALDH1A1 | |
| Bicarbonate SCHEMBL6150295 | 0.63 | CA1 (0.38) | CA12CA1CA9KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210011014-A1 | DETECTION AND ASSAY DEVICES AND METHODS OF MAKING AND USING THE SAME | HUCKNALL, ANGUS | 2021-01-14 | — | — | US | disclosed |
| US-20190285623-A1 | DETECTION AND ASSAY DEVICES AND METHODS OF MAKING AND USING THE SAME | Sentilus Holdco LLC (US) | 2019-09-19 | — | — | US | disclosed |
| US-10288607-B2 | Detection and assay devices and methods of making and using the same | Sentilus Holdco LLC (US) | 2019-05-14 | — | — | US | disclosed |
| US-20140228249-A1 | Detection and Assay Devices and Methods of Making and Using the Same | SENTILUS, INC. (US) | 2014-08-14 | — | — | US | disclosed |
| US-8796184-B2 | Detection assay devices and methods of making and using the same | SENTILUS, INC. (US) | 2014-08-05 | — | — | US | disclosed |
| US-20090247424-A1 | DETECTION ASSAY DEVICES AND METHODS OF MAKING AND USING THE SAME | DUKE UNIVERSITY (US) | 2009-10-01 | — | — | US | disclosed |
| US-20040259912-A1 | Benzine derivatives, process for preparing the same and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-1437344-A1 | BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-07-14 | — | — | EP | disclosed |
| EP-0820278-A4 | NON-IMMUNOGENIC, BIOCOMPATIBLE MACROMOLECULAR MEMBRANE COMPOSITIONS, AND METHODS FOR MAKING AND USING SAME | BIOMM INC (US) | 2004-06-09 | — | — | EP | disclosed |
| EP-0820278-A1 | NON-IMMUNOGENIC, BIOCOMPATIBLE MACROMOLECULAR MEMBRANE COMPOSITIONS, AND METHODS FOR MAKING AND USING SAME | Biomm, Incorporated (US) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996032098-A1 | NON-IMMUNOGENIC, BIOCOMPATIBLE MACROMOLECULAR MEMBRANE COMPOSITIONS, AND METHODS FOR MAKING AND USING SAME | BIOMM, INCORPORATED (US) | 1996-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259912-A1 | Benzine derivatives, process for preparing the same and use thereof | HRH4, HRH2, HRH1 | CA12 4703/4885CA1 3612/4885CA9 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.